Advenchen Laboratories Nanjing Ltd.

This early-stage trial is testing an oral drug called AL58805 in 40 people with advanced solid tumors who have run out of standard treatment options. The main goals are to find a safe dose, identify side effects, and understand how the drug moves through the body. Researchers wil…